Evaluation on the Efficacy of Bronchodilator Nebulization Via High Flow Nasal Cannula
Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
High-humidity nasal cannula (HFNC) has been shown to be effective in improving oxygenation
and avoiding intubation in multiple randomized control trials, it is also suitable and
feasible for long term use. Aerosol delivery via HFNC will minimize interruptions and improve
patient compliance, bench study and radionuclide imaging study done in healthy volunteers
demonstrated that aerosol can be effectively delivered using HFNC. This study aims to
evaluate the efficacy of bronchodilator delivered via HFNC in chronic pulmonary obstructive
disease or asthma patients.
Phase:
N/A
Details
Lead Sponsor:
Rush University Medical Center
Collaborator:
People's Hospital of Xinjiang Uygur Autonomous Region